- Letter to the Editor
- Open Access
Survey of acute exacerbation after nonpulmonary surgery in patients with interstitial pneumonia
JA Clinical Reports volume 7, Article number: 29 (2021)
To the Editor:
Acute exacerbation (AE) of interstitial pneumonia (IP) is described as an acute respiratory deterioration accompanied by newly developed bilateral ground-glass opacity and/or consolidation identified on chest radiographs or computed tomography (CT) scans. It occurs in 9.3–15.8% of patients with IP undergoing pulmonary surgery and has a high fatality rate [1,2,3]. In contrast, limited data exists on the incidence of AE after nonpulmonary surgery; only three reports have been published so far, and the reported incidence deviates from 1.4 to 6.3% [4,5,6]. One of these reports compared the incidences of AE after pulmonary and nonpulmonary surgeries but noted no significant difference . In this study, we examined the incidence of AE within 30 days after nonpulmonary surgery in patients with IP.
Figure 1 shows the flow diagram of this study. We included 220 patients with IP undergoing nonpulmonary surgery under general anesthesia at Kyoto University Hospital between 2008 and 2017. Patients with IP were identified by screening using the 10th revision of the International Statistical Classification of Diseases and Related Health Problems (ICD-10) diagnosis codes, followed by a review of chest CT reports. The diagnosis of AE was made based on the same criteria used in previous studies: (1) new bilateral ground-glass opacity/consolidation identified on chest CT, (2) acute worsening or development of dyspnea noted in the medical records, and (3) exclusion of heart failure, excessive fluid infusion, or lung infection as causes [4,5,6].
Table 1 shows the characteristics and operative variables of patients included in this study. No patients who underwent nonpulmonary surgery reported AE within 30 days after surgery; two patients presented with new infiltrative shadows on chest CT within 30 days after surgery, both of which were unilateral and caused by lung infection. The incidence of AE after nonpulmonary surgery was estimated to be 1.5% (95% confidence interval: 0.9–2.4%), when the result of this study was integrated with those of previous studies [4,5,6]. On the other hand, one of the 32 patients with IP undergoing pulmonary surgery had AE within 30 days after surgery.
The incidence of AE after nonpulmonary surgery estimated in this study tended to be lower than that reported in previous studies, possibly because fewer patients had known risk factors for postoperative AE, such as usual IP pattern, AE history, and a high C-reactive protein level (Table 1) . The data of this study could reinforce the hypothesis that postoperative AE is less common in patients undergoing nonpulmonary surgery than those undergoing pulmonary surgery, although the previous study did not find any significant difference in the incidence of postoperative AE between pulmonary and nonpulmonary surgeries .
Due to various limitations, further validation of our findings is warranted. For example, few patients in this study had known AE risk factors, which may be due to the exclusion of high-risk patients from surgical treatment. Our study and all other previous studies have been carried out in Japan, thereby limiting the generalization of results to other settings.
Availability of data and materials
The datasets used and analyzed in this study are available from the corresponding author on a reasonable request.
International Statistical Classification of Diseases and Related Health Problems - 10th revision
Chida M, Kobayashi S, Karube Y, Hayama M, Tamura M, Ishihama H, et al. Incidence of acute exacerbation of interstitial pneumonia in operated lung cancer: institutional report and review. Ann Thorac Cardiovasc Surg. 2012;18(4):314–7. https://doi.org/10.5761/atcs.oa.11.01839.
Sato T, Teramukai S, Kondo H, Watanabe A, Ebina M, Kishi K, et al. Impact and predictors of acute exacerbation of interstitial lung diseases after pulmonary resection for lung cancer. J Thorac Cardiovasc Surg. 2014;147(5):1604–11.e3.
Maniwa T, Kondo H, Mori K, Sato T, Teramukai S, Ebina M, et al. Outcomes in surgically managed non-small-cell lung cancer patients with evidence of interstitial pneumonia identified on preoperative radiology or incidentally on postoperative histology. Interact Cardiovasc Thorac Surg. 2015;20(5):641–6. https://doi.org/10.1093/icvts/ivv021.
Miyamura T, Sakamoto N, Kakugawa T, Okuno D, Yura H, Nakashima S, et al. Postoperative acute exacerbation of interstitial pneumonia in pulmonary and non-pulmonary surgery: a retrospective study. Respir Res. 2019;20(1):154. https://doi.org/10.1186/s12931-019-1128-5.
Takao S, Masuda T, Yamaguchi K, Sakamoto S, Horimasu Y, Nakashima T, et al. High preoperative C-reactive protein level is a risk factor for acute exacerbation of interstitial lung disease after non-pulmonary surgery. Medicine (Baltimore). 2019;98(5):e14296. https://doi.org/10.1097/MD.0000000000014296.
Hosoki K, Mikami Y, Urushiyama H, Souma K, Kawamura G, Uchida K, et al. Predictors of postoperative acute exacerbation of interstitial lung disease: a case-control study. BMJ Open Respir Res. 2020;7(1):e000634. https://doi.org/10.1136/bmjresp-2020-000634.
We would like to thank Enago (www.enago.jp) for the English language review.
This work was supported by the JSPS KAKENHI (grant number 20K09242; TM, principal investigator).
Ethics approval and consent to participate
This study was approved by the ethics committee of Kyoto University Hospital (approval number: R2647), and the requirement for informed consent was waived.
Consent for publication
The authors declare that they have no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Hamada, M., Wakata, R., Sato, M.S. et al. Survey of acute exacerbation after nonpulmonary surgery in patients with interstitial pneumonia. JA Clin Rep 7, 29 (2021). https://doi.org/10.1186/s40981-021-00433-z